BMED ETF
iShares Health Innovation Active ETF
GILD is BMED's largest holding at 5.89% of the fund as of Nov 1, 2026. BMED is iShares Health Innovation Active ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | G | Gilead Sciences IncHealth Care · Pharmaceuticals | 5.89% | 5.9% | 5,033 | $859.0K | Health Care | Pharmaceuticals |
| 2 | Debt | Blackrock Cash Funds: Treasury, Sl Agency SharesFinancials · Capital Markets | 5.28% | 11.2% | 770,000 | $770.0K | Financials | Capital Markets |
| Sector and industry · Pro | ||||||||
| 3 | M | Moderna Inc | 5.28% | 16.4% | 3,476 | $770.7K | ||
| 4 | D | Danaher Corp | 5.15% | 21.6% | 3,232 | $750.6K | ||
| 5 | A | AbbVie Inc. | 4.92% | 26.5% | 2,431 | $716.9K | ||
| 6 | — | Thermo Fisher | 4.31% | 30.8% | 902 | $628.7K | ||
| 7 | B | Biogen Inc | 3.74% | 34.6% | 2,150 | $545.3K | ||
| 8 | I | IQVIA Holdings Inc | 3.53% | 38.1% | 1,923 | $514.1K | ||
| 9 | M | Mettler-Toledo International Inc | 3.49% | 41.6% | 304 | $509.1K | ||
| 10 | V | Vertex Pharmaceuticals Inc | 3.39% | 45.0% | 884 | $494.1K | ||
| 11 | M | Merck & Company Inc | 3.02% | 48.0% | 2,943 | $440.0K | ||
| 12 | E | Edwards Lifesciences Corp | 2.99% | 51.0% | 4,736 | $435.8K | ||
| 13 | — | Roche Holding Ag- Genusschein | 2.87% | 53.9% | 853 | $418.1K | ||
| 14 | — | Genmab AS ADR | 2.83% | 56.7% | 7,231 | $412.6K | ||
| 15 | A | Amgen Inc. | 2.56% | 59.3% | 802 | $373.7K | ||
| 16 | A | Agilent Technologies Inc | 2.37% | 61.6% | 1,973 | $345.0K | ||
| 17 | H | Halozyme Therapeutics Inc | 2.27% | 63.9% | 2,531 | $331.3K | ||
| 18 | W | Waters Corp | 2.25% | 66.1% | 710 | $328.5K | ||
| 19 | D | DexCom Inc | 2.19% | 68.3% | 3,881 | $319.4K | ||
| 20 | — | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) | 1.70% | 70.0% | 277 | $247.3K | ||
| 21 | C | Charles River Laboratories International Inc | 1.70% | 71.7% | 689 | $247.6K | ||
| 22 | I | Illumina Inc | 1.61% | 73.3% | 995 | $234.8K | ||
| 23 | P | Pfizer Inc | 1.54% | 74.9% | 7,359 | $224.6K | ||
| 24 | G | Galderma Group AG | 1.44% | 76.3% | 896 | $209.9K | ||
| 25 | G | Guardant Health, Inc | 1.43% | 77.8% | 1,166 | $208.5K | ||
| 26 | — | Teva Pharmaceutical Industries Ltd. | 1.42% | 79.2% | 4,924 | $207.3K | ||
| 27 | N | Neurocrine Biosciences Inc | 1.38% | 80.6% | 1,382 | $201.9K | ||
| 28 | B | Bristol-Myers Squibb Co | 1.31% | 81.9% | 3,058 | $191.1K | ||
| 29 | — | Roivant Sciences Ltd. Common Shares | 1.31% | 83.2% | 5,171 | $190.9K | ||
| 30 | N | Novartis Ag Ordinary Shares | 1.31% | 84.5% | 1,171 | $190.3K | ||
| 31 | — | Abbot Laboratories | 1.27% | 85.8% | 1,746 | $185.4K | ||
| 32 | C | Cytokinetics Inc | 1.25% | 87.0% | 2,888 | $181.9K | ||
| 33 | M | Merck Kgaa | 1.25% | 88.3% | 1,075 | $181.6K | ||
| 34 | J | Johnson & Johnson - | 1.22% | 89.5% | 650 | $177.6K | ||
| 35 | — | Wuxi Biologics (cayman) Inc. | 1.13% | 90.6% | 29,000 | $164.4K | ||
| 36 | B | BioMarin Pharmaceutical Inc | 1.02% | 91.6% | 2,533 | $148.2K | ||
| 37 | C | Cencora Inc | 0.95% | 92.6% | 419 | $138.6K | ||
| 38 | — | Tempus PE | 0.87% | 93.4% | 1,749 | $126.3K | ||
| 39 | P | Protagonist Therapeutics Inc | 0.86% | 94.3% | 866 | $125.4K | ||
| 40 | — | Ucb SA | 0.80% | 95.1% | 370 | $116.2K | ||
| 41 | A | Axsome Therapeutics Inc | 0.71% | 95.8% | 721 | $104.1K | ||
| 42 | B | Bruker Corp | 0.64% | 96.5% | 1,648 | $94.1K | ||
| 43 | — | Alkermes PLC | 0.59% | 97.0% | 1,902 | $86.2K | ||
| 44 | R | Revolution Medicines Inc | 0.55% | 97.6% | 416 | $79.6K | ||
| 45 | D | Dianthus Therapeutics Inc | 0.50% | 98.1% | 890 | $73.3K | ||
| 46 | M | MBX Biosciences Inc | 0.42% | 98.5% | 1,103 | $61.6K | ||
| 47 | P | PTC Therapeutics Inc | 0.41% | 98.9% | 1,001 | $60.0K | ||
| 48 | C | Cogent Biosciences Inc | 0.39% | 99.3% | 1,813 | $56.2K | ||
| 49 | V | Viridian Therapeutics Inc | 0.34% | 99.7% | 2,025 | $50.0K | ||
| 50 | S | Sagimet Biosciences Inc Class A | 0.13% | 99.8% | 1,875 | $18.6K | ||
| More holdings · Pro | ||||||||
BMED ETF All Holdings
BMED holdings total 62 positions. The top 10 holdings account for 45.0% of the fund, led by Gilead Sciences Inc at 5.9%, Blackrock Cash Funds: Treasury, Sl Agency Shares at 5.3%, Moderna Inc at 5.3%.
BMED portfolio concentration is moderate, with the top 10 representing 45.0% of total assets. The largest sector exposure is Health Care at 82.6%.
BMED sectors provide a detailed breakdown. BMED overlap shows how holdings compare to other funds in your portfolio.
BMED ETF Holdings
62 of 62 holdings
- 1
Gilead Sciences Inc
GILDHealth Care5.89% - 2
Blackrock Cash Funds: Treasury, Sl Agency Shares
XTSLAFinancials5.28% - 3
Moderna Inc
MRNAHealth Care5.28% - 4
Danaher Corporation
DHRHealth Care5.15% - 5
Abbvie Inc.
ABBVHealth Care4.92% - 6
Thermo Fisher
TMOHealth Care4.31% - 7
Biogen Inc
BIIBHealth Care3.74% - 8
IQVIA Holdings Inc
IQVHealth Care3.53% - 9
Mettler-Toledo International Inc
MTDHealth Care3.49% - 10
Vertex Pharmaceuticals Inc
VRTXHealth Care3.39% - 11
Merck & Company Inc
MRKHealth Care3.02% - 12
Edwards Lifesciences Corp
EWHealth Care2.99% - 13
Roche Holding Ag- Genusschein
RHO5:FFUnknown2.87% - 14
Genmab AS ADR
GMAB:COHealth Care2.83% - 15
Amgen Inc.
AMGNHealth Care2.56% - 16
Agilent Technologies Inc
AInformation Technology2.37% - 17
Halozyme Therapeutics Inc
HALOHealth Care2.27% - 18
Waters Corp
WATHealth Care2.25% - 19
DexCom Inc
DXCMHealth Care2.19% - 20
Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
ARGX:ASHealth Care1.70% - 21
Charles River Laboratories International Inc
CRLHealth Care1.70% - 22
Illumina Inc
ILMNHealth Care1.61% - 23
Pfizer Inc
PFEHealth Care1.54% - 24
Galderma Group AG
GALD:SHUnknown1.44% - 25
Guardant Health, Inc
GHHealth Care1.43% - 26
Teva Pharmaceutical Industries Ltd.
TEVA:ILUnknown1.42% - 27
Neurocrine Biosciences Inc
NBIXHealth Care1.38% - 28
Bristol-Myers Squibb Co
BMYHealth Care1.31% - 29
Roivant Sciences Ltd. Common Shares
ROIV:BMHealth Care1.31% - 30
Novartis Ag Ordinary Shares
NOVN:SMHealth Care1.31% - 31
Abbot Laboratories
ABTHealth Care1.27% - 32
Cytokinetics Inc
CYTKHealth Care1.25% - 33
Merck Kgaa
MRCG:FFUnknown1.25% - 34
Johnson & Johnson - Common
JNJHealth Care1.22% - 35
Wuxi Biologics (cayman) Inc.
2269:HKUnknown1.13% - 36
BioMarin Pharmaceutical Inc
BMRNHealth Care1.02% - 37
Cencora Inc
CORHealth Care0.95% - 38
Tempus PE
TEMInformation Technology0.87% - 39
Protagonist Therapeutics Inc
PTGXHealth Care0.86% - 40
UCB SA
UCB:BRHealth Care0.80% - 41
Axsome Therapeutics Inc
AXSMHealth Care0.71% - 42
Bruker Corp
BRKRInformation Technology0.64% - 43
Alkermes PLC
ALKS:IEHealth Care0.59% - 44
Revolution Medicines Inc
RVMDHealth Care0.55% - 45
Dianthus Therapeutics Inc
DNTHHealth Care0.50% - 46
MBX Biosciences Inc
MBXHealth Care0.42% - 47
PTC Therapeutics Inc
PTCTHealth Care0.41% - 48
Cogent Biosciences Inc
COGTHealth Care0.39% - 49
Viridian Therapeutics Inc
VRDNHealth Care0.34% - 50
Sagimet Biosciences Inc Class A
SGMTHealth Care0.13% - 51
Summit Therapeutics Inc
SMMTHealth Care0.08% - 52
USD Cash
Other0.07% - 53
Eikon Therapeutics Inc
EIKNUnknown0.05% - 54
Avalo Therapeutics Inc
AVTXHealth Care0.04% - 55
Blueprint Medicines Corp
BPMCHealth Care0.00% - 56
Mirati Therapeutics Inc
MRTXUnknown0.00% - 57
HKD Cash
Other0.00% - 58
KRW Cash
Other0.00% - 59
Vigil Neuroscience Inc Cvr
Other0.00% - 60
Abiomed Cvrs
Other0.00% - 61
Gbp Cash
Other0.00% - 62
Korro Bio Inc Cvr
Other0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Gilead Sciences Inc | GILD | 5.890% | ||
| 2 | Blackrock Cash Funds: Treasury, Sl Agency Shares | XTSLA | 5.280% | ||
| 3 | Moderna Inc | MRNA | 5.280% | ||
| 4 | Danaher Corporation | DHR | 5.150% | ||
| 5 | Abbvie Inc. | ABBV | 4.920% | ||
| 6 | Thermo Fisher | TMO | 4.310% | ||
| 7 | Biogen Inc | BIIB | 3.740% | ||
| 8 | IQVIA Holdings Inc | IQV | 3.530% | ||
| 9 | Mettler-Toledo International Inc | MTD | 3.490% | ||
| 10 | Vertex Pharmaceuticals Inc | VRTX | 3.390% | ||
| 11 | Merck & Company Inc | MRK | 3.020% | ||
| 12 | Edwards Lifesciences Corp | EW | 2.990% | ||
| 13 | Roche Holding Ag- Genusschein | RHO5:FF | 2.870% | ||
| 14 | Genmab AS ADR | GMAB:CO | 2.830% | ||
| 15 | Amgen Inc. | AMGN | 2.560% | ||
| 16 | Agilent Technologies Inc | A | 2.370% | ||
| 17 | Halozyme Therapeutics Inc | HALO | 2.270% | ||
| 18 | Waters Corp | WAT | 2.250% | ||
| 19 | DexCom Inc | DXCM | 2.190% | ||
| 20 | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) | ARGX:AS | 1.700% | ||
| 21 | Charles River Laboratories International Inc | CRL | 1.700% | ||
| 22 | Illumina Inc | ILMN | 1.610% | ||
| 23 | Pfizer Inc | PFE | 1.540% | ||
| 24 | Galderma Group AG | GALD:SH | 1.440% | ||
| 25 | Guardant Health, Inc | GH | 1.430% | ||
| 26 | Teva Pharmaceutical Industries Ltd. | TEVA:IL | 1.420% | ||
| 27 | Neurocrine Biosciences Inc | NBIX | 1.380% | ||
| 28 | Bristol-Myers Squibb Co | BMY | 1.310% | ||
| 29 | Roivant Sciences Ltd. Common Shares | ROIV:BM | 1.310% | ||
| 30 | Novartis Ag Ordinary Shares | NOVN:SM | 1.310% | ||
| 31 | Abbot Laboratories | ABT | 1.270% | ||
| 32 | Cytokinetics Inc | CYTK | 1.250% | ||
| 33 | Merck Kgaa | MRCG:FF | 1.250% | ||
| 34 | Johnson & Johnson - Common | JNJ | 1.220% | ||
| 35 | Wuxi Biologics (cayman) Inc. | 2269:HK | 1.130% | ||
| 36 | BioMarin Pharmaceutical Inc | BMRN | 1.020% | ||
| 37 | Cencora Inc | COR | 0.950% | ||
| 38 | Tempus PE | TEM | 0.870% | ||
| 39 | Protagonist Therapeutics Inc | PTGX | 0.860% | ||
| 40 | UCB SA | UCB:BR | 0.800% | ||
| 41 | Axsome Therapeutics Inc | AXSM | 0.710% | ||
| 42 | Bruker Corp | BRKR | 0.640% | ||
| 43 | Alkermes PLC | ALKS:IE | 0.590% | ||
| 44 | Revolution Medicines Inc | RVMD | 0.550% | ||
| 45 | Dianthus Therapeutics Inc | DNTH | 0.500% | ||
| 46 | MBX Biosciences Inc | MBX | 0.420% | ||
| 47 | PTC Therapeutics Inc | PTCT | 0.410% | ||
| 48 | Cogent Biosciences Inc | COGT | 0.390% | ||
| 49 | Viridian Therapeutics Inc | VRDN | 0.340% | ||
| 50 | Sagimet Biosciences Inc Class A | SGMT | 0.130% | ||
| 51 | Summit Therapeutics Inc | SMMT | 0.080% | ||
| 52 | USD Cash | - | 0.070% | ||
| 53 | Eikon Therapeutics Inc | EIKN | 0.050% | ||
| 54 | Avalo Therapeutics Inc | AVTX | 0.040% | ||
| 55 | Blueprint Medicines Corp | BPMC | 0.000% | ||
| 56 | Mirati Therapeutics Inc | MRTX | 0.000% | ||
| 57 | HKD Cash | - | 0.000% | ||
| 58 | KRW Cash | - | 0.000% | ||
| 59 | Vigil Neuroscience Inc Cvr | - | 0.000% | ||
| 60 | Abiomed Cvrs | - | 0.000% | ||
| 61 | Gbp Cash | - | 0.000% | ||
| 62 | Korro Bio Inc Cvr | - | 0.000% |





































